Literature DB >> 8880206

Non-AIDS-defining cancers.

S C Remick1.   

Abstract

As the AIDS epidemic advances, the spectrum of malignancies encountered is expanding. Several non-AIDS-defining cancers are seen in increased incidence in HIV-infected patients. These include basal cell carcinoma of the skin, squamous cell carcinoma of the anus, Hodgkin's disease, seminoma, and pediatric leiomyosarcoma. There appears to be an emerging role for various concurrent viral infections in the HIV-infected host that are likely implicated in the pathogenesis of AIDS-related neoplasms. It will be important to track the epidemiologic and biologic features of non-AIDS cancers in HIV-infected patients. It is likely that further clues about malignant transformation and oncogenesis unraveled in this setting will have broader clinical implications.

Entities:  

Mesh:

Year:  1996        PMID: 8880206     DOI: 10.1016/s0889-8588(05)70394-4

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  4 in total

1.  Is there an association between human immunodeficiency virus infection and breast cancer?

Authors:  Hamid Salim Shaaban; Yashpal Modi; Gunwant Guron
Journal:  Med Oncol       Date:  2012-06       Impact factor: 3.064

2.  Impact of HAART on causes of death of persons with late-stage AIDS.

Authors:  G R Sansone; J D Frengley
Journal:  J Urban Health       Date:  2000-06       Impact factor: 3.671

3.  Time for oncologists to opt in for routine opt-out HIV testing?

Authors:  Elizabeth Y Chiao; Bruce J Dezube; Susan E Krown; William Wachsman; Malcolm V Brock; Thomas P Giordano; Ronald Mitsuyasu; Liron Pantanowitz
Journal:  JAMA       Date:  2010-07-21       Impact factor: 56.272

Review 4.  Microenvironmental regulation of the progression of oral potentially malignant disorders towards malignancy.

Authors:  Ruixue Ai; Yan Tao; Yilong Hao; Lu Jiang; Hongxia Dan; Ning Ji; Xin Zeng; Yu Zhou; Qianming Chen
Journal:  Oncotarget       Date:  2017-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.